Additionally, other relevant outcomes of transplantation therapies for T1DM include decreased insulin requirements, reduced glucose variability, increased time in range as detected by continuous glucose monitoring, and a decreased rate of microvascular and macrovascular complications. The gene discussed is INS; the disease is type 1 diabetes mellitus.